And the antioxidant is the defense mechanism of human body against free radicals. We should first understand what foods containing antioxidants most. These nutrients help mitigate and prevent oxidative damage to the body. In fact, only need to put the antioxidants food and fruit in the daily diet, it can prevent many diseases. Specifically, the […]
Read More
POLYUNSATURATED vegetable oils from plants like soybeans and sunflowers are generally praised by nutritionists because they help people keep their cholesterol down and, it is believed, avoid heart disease. But a new study reports that when used to fry foods, the oils produce a toxic compound that has been associated with illnesses, including cardiovascular disease, […]
Read More
Surviving Multiple Myeloma – Mayo Clinic Multiple myeloma is a type of cancer for which there is no cure. But treatment for this disease has improved greatly in recent years. Patients can live in remission for a long time. The man you’re about to meet was diagnosed with multiple myeloma last year, and after an […]
Read More
Cancer Cells in Endometrial Cysts Could Lead to Earlier Ovarian Cancer Detection [unable to retrieve full-text content] Researchers have found that endometriosis-associated ovarian cancer (EAOC) often occurs within 36 months of follow-up for endometrial cysts, …Published at Mon, 17 Aug 2020 20:54:05 +0000
Read More -mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial [unable to retrieve full-text content] The combination of dabrafenib and trametinib has shown activity in several BRAFV600E-mutated cancers. We aimed to assess the activity and safety of …Published at Mon, 17 Aug 2020 22:30:00 +0000
Read More
First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that the first patient has been dosed in a Phase I/II study of Telix’s […]
Read More
Dr. Wong on the Potential Role of Venetoclax in Relapsed/Refractory AL Amyloidosis Sandy Wong, MD, discusses the potential role of venetoclax in relapsed/refractory light chain amyloidosis. Sandy Wong, MD, assistant professor, University of California, San Francisco (UCSF) School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the potential role of venetoclax (Venclexta) in […]
Read More
Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field […]
Read More
Blood Cancer Drugs Market Size, Share, Growth, Trends, and Forecast, 2019 to 2023 Global “Blood Cancer Drugs market”- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2019 to 2025. The report Blood Cancer Drugs offers a complete market outlook and development rate during the past, […]
Read More